RxDoctor Payments Data

Sammy Elmariah, MD

Interventional Cardiology · San Francisco, CANPI 1659350858

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 91.9% of it on its own, with 4 other manufacturers making up the rest. Among interventional cardiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$125,856in general payments, 2019–2025

Across 289 payments — averaging $435.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$116K
  • Medtronic$7K
  • Abbott$3K
  • Boston Scientific$411
  • Abiomed$122
$4,055,798in research payments, 2019–2025

Across 331 payments — averaging $12,253 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$3.7M
  • Abbott$178K
  • Medtronic$163K
  • W. L. Gore & Associates, Inc.$40K
  • Novartis$24K

What the payments were for

  • Consulting fees$73,60158%
  • Speaking & faculty fees$16,80013%
  • Travel & lodging$21,92317%
  • Food & beverage$13,53211%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences224$115,637
Medtronic(2 entities)32$6,745
Abbott27$2,941
Boston Scientific5$411
Abiomed1$122

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$125,856 in reported general payments places this provider in the 90th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California

Medicare billing

Part B allowed, 2024
$116,083
Medicare patients
160
Services billed
403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →